Major population differences in T cell response to a malaria sporozite vaccine candidate Article

Zevering, Y, Houghten, RA, Frazer, IH et al. (1990). Major population differences in T cell response to a malaria sporozite vaccine candidate . 2(10), 945-955. 10.1093/intimm/2.10.945

cited authors

  • Zevering, Y; Houghten, RA; Frazer, IH; Good, MF

authors

abstract

  • Using a complete series of overlapping peptides, we have identified the T cell epitopes of a malaria vaccine candidate, the circumsporozoite (CS) protein, that are recognized by sporozoiteexposed residents of a non-endemic country. Thls protein and subunb from tt are belng considered as malarla sporozoite vaccine candidates, as CS-specific antibodies and cytotoxic T lymphocytes have been shown to have a role in protection. The rationale for deveioplng an antibody-based vaccine is that in Plasmodium falclpmmthe lmmunodominant B cell epttope of the protein, (Asn-AieAsn-Ala-Asn-Pro)n, [(NANP)n], is invariant. However, the Ideal vaccine must contain CS protein-derived T cell antigenlc epttopes to allow natural boosting of the antibody response following sporozoite exposure. Here, we show that major differences occur between the CS spectific T cell responses of non-endemic Caucasians and an endemic African population. HLA differencaa between the populations are, in part, responsible. Subunit malaria vacclnes for one population may be ineffective In a different population. © Oxford University Press.

publication date

  • October 1, 1990

Digital Object Identifier (DOI)

start page

  • 945

end page

  • 955

volume

  • 2

issue

  • 10